Patent details

EP1910341 Title: INHIBITORS OF SERINE PROTEASES

Basic Information

Publication number:
EP1910341
PCT Application Number:
PCT/US/2006/029988
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP068006337
PCT Publication Number:
WO/2007/016589
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INHIBITORS OF SERINE PROTEASES
French Title of Invention:
INHIBITEURS DES SERINES PROTEASES
German Title of Invention:
SERINPROTEASE-HEMMER
SPC Number:

Dates

Filing date:
01/08/2006
Grant date:
02/01/2013
EP Publication Date:
02/01/2013
PCT Publication Date:
08/02/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/04/2008
EP B1 Publication Date:
02/01/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/08/2026
Renunciation date:
Revocation date:
01/08/2013
Annulment date:

Owner

From:
01/08/2014
 
 

Name:
Vertex Pharmaceuticals Incorporated
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)

Inventor

1

Name:
PERNI Robert, B.
Address:
United States (US)

2

Name:
LYONS Steve
Address:
United States (US)

Priority

Priority Number:
704772 P
Priority Date:
02/08/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 403/12;
Filing date Document type Number of pages